Literature DB >> 16461190

Effect of age on blood pressure parameters and risk of cardiovascular death in men.

Thomas S Bowman1, Howard D Sesso, J Michael Gaziano.   

Abstract

BACKGROUND: Elevated blood pressure (BP) is a risk factor for cardiovascular disease (CVD), but it remains unclear which component-alone or in combination-is the best predictor. We sought to determine which BP parameters are important predictors of CVD death across a wide age range.
METHODS: We used a prospective cohort study design with 53,163 men followed for cause-specific death during a median of 5.7 years in the Physicians' Health Study enrollment cohort. Baseline age, systolic BP and diastolic BP were collected. We calculated relative risks (RRs) and their 95% confidence intervals using Cox proportional hazard models adjusting for major risk factors for CVD, and then stratified by age (39 to 49, 50 to 59, 60 to 69, and 70 to 84 years).
RESULTS: There were 459 CVD deaths during follow-up. For each 10 mm Hg increase in systolic BP, the multivariable RRs by ascending age group were 1.46, 1.43, 1.24, and 1.13. The multivariable RRs for each 10 mm Hg increase in diastolic BP were 1.25, 1.20, 1.28, and 1.07. Compared with systolic BP, pulse pressure and mean arterial pressure were not consistent predictors across age ranges, and combining systolic BP with another parameter did not improve the model compared with using systolic BP alone in any age group (all P > .05).
CONCLUSIONS: In this large cohort of healthy men with no history of hypertension, systolic BP was the most consistent and significant predictor of CVD death across all ages. Diastolic BP was not as strongly associated with risk. Our results support the continuing emphasis on using systolic BP in predicting cardiovascular risk.

Entities:  

Mesh:

Year:  2006        PMID: 16461190     DOI: 10.1016/j.amjhyper.2005.06.024

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  7 in total

1.  Olmesartan medoxomil in elderly patients with essential or isolated systolic hypertension : efficacy and safety data from clinical trials.

Authors:  Anthony M Heagerty; Jean-Michel Mallion
Journal:  Drugs Aging       Date:  2009       Impact factor: 3.923

2.  Long-term blood pressure trajectories and associations with age and body mass index among urban women in South Africa.

Authors:  Muchiri E Wandai; Samuel O Manda; Jens Aagaard-Hansen; Shane A Norris
Journal:  Cardiovasc J Afr       Date:  2021-07-26       Impact factor: 1.167

Review 3.  Brachial pulse pressure and cardiovascular or all-cause mortality in the general population: a meta-analysis of prospective observational studies.

Authors:  Leilei Zhao; Yijuan Song; Pingshuan Dong; Zhijuan Li; Xuming Yang; Shaoxin Wang
Journal:  J Clin Hypertens (Greenwich)       Date:  2014-07-23       Impact factor: 3.738

4.  Evaluation of prothrombin time and activated partial thromboplastin time in hypertensive patients attending a tertiary hospital in calabar, Nigeria.

Authors:  Nnamani Nnenna Adaeze; Anthony Uchenna Emeribe; Idris Abdullahi Nasiru; Adamu Babayo; Emmanuel K Uko
Journal:  Adv Hematol       Date:  2014-11-16

Review 5.  Assessing Sex Differences in the Risk of Cardiovascular Disease and Mortality per Increment in Systolic Blood Pressure: A Systematic Review and Meta-Analysis of Follow-Up Studies in the United States.

Authors:  Yu-Chung Wei; Nysia I George; Ching-Wei Chang; Karen A Hicks
Journal:  PLoS One       Date:  2017-01-25       Impact factor: 3.240

6.  Does vitamin D deficiency contribute to erectile dysfunction?

Authors:  Marc Sorenson; William B Grant
Journal:  Dermatoendocrinol       Date:  2012-04-01

7.  Synergistic effects of elevated homocysteine level and abnormal blood lipids on the onset of stroke.

Authors:  Lu Hao; Liming Chen; Xiaoyong Sai; Zhefeng Liu; Guang Yang; Rongzeng Yan; Lili Wang; Caiyun Fu; Xuan Xu; Zhenzhen Cheng; Qiang Wu; Shuzhang Li
Journal:  Neural Regen Res       Date:  2013-11-05       Impact factor: 5.135

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.